Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Apellis Pharmaceuticals, Inc. | StockGist | StockGist

Companies
APLS
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings APLSSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Apellis Pharmaceuticals, Inc.

Filed Feb 6, 2026

Accepted Feb 6, 2026, 12:00 AM ET

CIK 0001492422

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Apellis Pharmaceuticals, Inc.

Person Type

HC

CUSIP: 03753U106

Amendment History

6 filings

SCHEDULE 13G
Original
Viewing
Feb 6, 20260002012383-26-000899
SCHEDULE 13G/A
Amendment 1
Feb 10, 20250000902219-25-000121
SCHEDULE 13G/A
Amendment 2
Apr 25, 20250002052113-25-001714
SCHEDULE 13G/A
Amendment 3
Aug 12, 20250000902219-25-000281
SCHEDULE 13G/A
Amendment 4
Nov 7, 20250000902219-25-000371
SCHEDULE 13G/A
Amendment 5
Latest
Nov 14, 20250000935836-25-000697

Recent Filings

Apellis Pharmaceuticals, Inc.4 days ago

Apellis Pharmaceuticals, Inc.1 weeks ago

Apellis Pharmaceuticals, Inc.1 months ago

Apellis Pharmaceuticals, Inc.1 months ago

Apellis Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice